Evaluating the effects of electroconvulsive therapy on depression

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This project aims to assess both the immediate and long-term outcomes of electroconvulsive therapy (ECT) in patients with major depressive disorder. Patients referred for ECT will be enrolled in a research registry after providing written consent. The study will evaluate depressive symptoms and cognitive function through clinician and patient-rated measures, identifying factors that predict response, remission, side effects, and relapse over a six-month period. Additionally, the duration of potential cognitive impairment and predictors of cognitive outcomes will be examined.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Patients treated with ECT for major depression (F31.3-5, F32, F33) at Haukeland University Hospital or Stavanger University Hospital after 2013,
* written consent to enrolment into the Regional Register for neurostimulation.

Exclusion Criteria:

* ECT performed on other indications than major depression.
* No consent to the register.

Where it's running

• Haukeland University Hospital
  Bergen, Norway Recruiting
• Stavanger University Hospital
  Stavanger, Norway Recruiting

Study contacts

• Study coordinator: Ute Kessler, PhD
• Email: ute.kessler@helse-bergen.no

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Understanding anxiety, depression, and bipolar disorder over time in China

  This study tests how anxiety, depressive, and bipolar symptoms change over three years to find patterns that help with earlier recognition and prediction in people aged 12–55.

  Recruiting Second Affiliated Hospital, Zhejiang University, School of Medicine · Hangzhou, Zhejiang · NCT07903246

• Aerobic Exercise as an Adjunct Therapy for Depression

  This study tests whether adding a structured aerobic exercise program to standard antidepressant and therapy helps reduce depression severity more than standard care alone.

  Recruiting Combined Military Hospital Bahawalpur · Chak Eighty-seven -Twelve Left, Punjab Province · NCT07819448

• Group Unified Protocol for Emotional Disorders in adults in public mental health (UP in Spanish)

  A group-based Spanish version of the Unified Protocol is being tested with adults in public mental health to see if it helps anxiety, depression, and related symptoms.

  Recruiting University of La Rioja · Logroño, La Rioja · NCT07682064

• Metformin added to antidepressants for depression with obesity in Pakistani adults

  This study tests whether adding metformin to antidepressant therapy helps reduce depressive symptoms and BMI in adults with depression and overweight/obesity in Pakistan.

  Recruiting at 2 sites Riphah International University · Rawalpindi, Punjab Province and 1 other locations · NCT07654179

• Parent group program using the Unified Protocol for teens with autism and anxiety/depression

  This trial tests a parent-guided adaptation of the Unified Protocol to help adolescents with autism and co-occurring anxiety or depression.

  Recruiting Sahlgrenska University Hospital · Gothenburg · NCT07637799

• Mindfulness‑augmented brain stimulation for treatment‑resistant depression

  This trial will test whether combining fast brain stimulation (iTBS) with a digital mindfulness program helps people with treatment‑resistant depression reduce symptoms and improve thinking.

  Recruiting Phase 2 University of California, San Diego · San Diego, California · NCT07512284

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.